Getty imagesA vaccination program is to be extended to deal with respiratory synchronous virus (RSV) to cover infants prematurely in Northern Ireland.
A long acting injection is to be offered for this autumn characters.
RSV is a common, but highly infectious, respiratory virus that affects the breathing system, especially in young children and large adults.
It infects 90% of children by the age of two and is one of the major reasons for hospitalization in the first year of life.
An RSV vaccine has been available for pregnant women in northern Ireland since last September and has been introduced for 28 weeks of pregnancy.
The new program will produce infants a long time and very quickly, which are very early to benefit from RSV vaccination given to their mothers.
Single Nirchavimab injection provides approximately 80% protection and replaces Palivizub, which provides 55% protection and is administered up to five times.
It follows advice from the Joint Committee on vaccination and vaccination.
Pacemaker pressChief Medical Officer Sir Michael McBrid said: “Vaccination has been extremely effective in eliminating diseases and protecting children and other weak groups from serious illness and death.
“It is a matter of concern, we are now seeing a decline in childhood vaccination.
“Vaccination gives children the best start in life. Quite bus, if children are not vaccinated, they are not protected.”
Health Minister Mike Nesbit said that the new vaccine will strengthen winter preparations in healthcare and reduce the pressure on GPS, emergency departments and hospital entry.
